Literature DB >> 22302786

The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.

Matthew J Butcher1, Breanne N Gjurich, Tracy Phillips, Elena V Galkina.   

Abstract

RATIONALE: Atherosclerosis is a disease of large- and medium-sized arteries that is characterized by chronic vascular inflammation. While the role of Th1, Th2, and T-regulatory subsets in atherogenesis is established, the involvement of IL-17A-producing cells remains unclear.
OBJECTIVE: To investigate the role of the IL-17A/IL-17RA axis in atherosclerosis. METHODS AND
RESULTS: We bred apolipoprotein-E-deficient (Apoe(-/-)) mice with IL-17A-deficient and IL-17 receptor A-deficient mice to generate Il17a(-/-)Apoe(-/-) and Il17ra(-/-)Apoe(-/-) mice. Western diet fed Il17a(-/-)Apoe(-/-) and Il17ra(-/-)Apoe(-/-) mice had smaller atherosclerotic plaques in the aortic arch and aortic roots, but showed little difference in plaque burden in the thoracoabdominal aorta in comparison with Apoe(-/-) controls. Flow cytometric analysis of Il17a(-/-)Apoe(-/-) and Il17ra(-/-)Apoe(-/-) aortas revealed that deficiency of IL-17A/IL-17RA preferentially reduced aortic arch, but not thoracoabdominal aortic T cell, neutrophil, and macrophage content in comparison with Apoe(-/-) aortic segments. In contrast to ubiquitous IL-17RA expression throughout the aorta, IL-17A was preferentially expressed within the aortic arch of WD-fed Apoe(-/-) mice. Deficiency of IL-17A or IL-17RA reduced aortic arch, but not thoracoabdominal aortic TNFα and CXCL2 expression. Aortic vascular IL-17RA supports monocyte adherence to explanted aortas in ex vivo adhesion assays. Short-term homing experiments revealed that the recruitment of adoptively transferred monocytes and neutrophils to the aortas of Il17ra(-/-)Apoe(-/-) mice is impaired in comparison with Apoe(-/-) recipients.
CONCLUSIONS: The IL-17A/IL-17RA axis increases aortic arch inflammation during atherogenesis through the induction of aortic chemokines, and the acceleration of neutrophil and monocyte recruitment to this site.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302786      PMCID: PMC3337709          DOI: 10.1161/CIRCRESAHA.111.261784

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  34 in total

1.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Authors:  Frank Tacke; David Alvarez; Theodore J Kaplan; Claudia Jakubzick; Rainer Spanbroek; Jaime Llodra; Alexandre Garin; Jianhua Liu; Matthias Mack; Nico van Rooijen; Sergio A Lira; Andreas J Habenicht; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 2.  Current views on the functions of interleukin-17A-producing cells in atherosclerosis.

Authors:  M Butcher; E Galkina
Journal:  Thromb Haemost       Date:  2011-09-22       Impact factor: 5.249

3.  p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.

Authors:  P A Barry-Lane; C Patterson; M van der Merwe; Z Hu; S M Holland; E T Yeh; M S Runge
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice.

Authors:  Victoria L King; Stephen J Szilvassy; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

Review 5.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

6.  Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.

Authors:  Keiko Danzaki; Yutaka Matsui; Masahiro Ikesue; Daichi Ohta; Koyu Ito; Masashi Kanayama; Daisuke Kurotaki; Junko Morimoto; Yoichiro Iwakura; Hideo Yagita; Hiroyuki Tsutsui; Toshimitsu Uede
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

7.  Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells.

Authors:  Jill F Wright; Yongjing Guo; Amira Quazi; Deborah P Luxenberg; Frann Bennett; John F Ross; Yongchang Qiu; Matthew J Whitters; Kathleen N Tomkinson; Kyri Dunussi-Joannopoulos; Beatriz M Carreno; Mary Collins; Neil M Wolfman
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

Review 8.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

9.  A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses.

Authors:  Seon Hee Chang; Chen Dong
Journal:  Cell Res       Date:  2007-05       Impact factor: 25.617

Review 10.  Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators.

Authors:  Paul A VanderLaan; Catherine A Reardon; Godfrey S Getz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-11-06       Impact factor: 8.311

View more
  75 in total

Review 1.  Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease.

Authors:  Y Imai; A D Dobrian; J R Weaver; M J Butcher; B K Cole; E V Galkina; M A Morris; D A Taylor-Fishwick; J L Nadler
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

2.  IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Authors:  Christian Erbel; Mohammadreza Akhavanpoor; Deniz Okuyucu; Susanne Wangler; Alex Dietz; Li Zhao; Konstantinos Stellos; Kristina M Little; Felix Lasitschka; Andreas Doesch; Maani Hakimi; Thomas J Dengler; Thomas Giese; Erwin Blessing; Hugo A Katus; Christian A Gleissner
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 3.  Adaptive immunity in atherogenesis: new insights and therapeutic approaches.

Authors:  Andrew H Lichtman; Christoph J Binder; Sotirios Tsimikas; Joseph L Witztum
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 4.  Regulation of atherogenesis by chemokine receptor CCR6.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Trends Cardiovasc Med       Date:  2011-07       Impact factor: 6.677

Review 5.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

6.  Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Authors:  Manikandan Subramanian; Edward Thorp; Goran K Hansson; Ira Tabas
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

Review 7.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Authors:  Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

Review 8.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

9.  CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas.

Authors:  Matthew J Butcher; Chih-I Wu; Tayab Waseem; Elena V Galkina
Journal:  Int Immunol       Date:  2015-11-27       Impact factor: 4.823

10.  Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jihyun Lee; William M Baldwin; Chih-Yuan Lee; Stephen Desiderio
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.